TickerFacts.

Baird Medical Investment Holdings Ltd (BDMD): R&D Expense

Annual figures by period end, from SEC filings.

$20.13M
Year ended 2025-12-31
+73.4%
3-year compound annual growth
2022-12-31: $3.86M2023-12-31: $4.27M2024-12-31: $6.17M2025-12-31: $20.13M$20.13M
2022-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$20.13M+226.0%2026-07-27, From 2025-01-01
2024-12-31$6.17M+44.4%2026-07-27, From 2024-01-01
2023-12-31$4.27M+10.8%2026-07-27, From 2023-01-01
2022-12-31$3.86Mn/a2025-05-15, From 2022-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$20.13M+226.0%
DarioHealth Corp. (DRIO)2025-12-31$13.79M-43.0%
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$2.27M+25.2%
Nephros Inc (NEPH)2025-12-31$1.34M+47.8%
Sensus Healthcare, Inc. (SRTS)2025-12-31$7.78M+84.5%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$100.0K0.0%
Profound Medical Corp. (PROF)2025-12-31$20.60M+21.4%
Biotricity Inc. (BTCY)2026-03-31$2.76M+28.2%
Allurion Technologies, Inc. (ALUR)2025-12-31$7.57M-56.4%

Compare BDMD, DRIO, SNOA, NEPH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗